We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Oxygen Device for Premature Babies

By HospiMedica staff writers
Posted on 08 Jan 2004
A compact and inexpensive device has been developed for use in developing countries to provide oxygen and atmospheric air to premature babies suffering from respiratory problems.

Called Oxymix, the device ensures the appropriate air/oxygen mix by supplying the correct flow rate of any concentration of oxygen, from 21-100%, from a single 100% oxygen gas supply. More...
Hospitals in many developing countries have access to medical-grade compressed oxygen but not to medical-grade compressed air. In such hospitals, babies with respiratory difficulties are often put in an oxygen hood, which is supplied with a small amount of pure oxygen. However, the build-up of the baby's exhaled carbon dioxide can cause serious problems, Also, the level of oxygen is hard to maintain. If it is too high, it can cause blindness, but if it is too low, it can cause brain damage.

In modern hospitals, the alternative products are either a very expensive air/oxygen blender or a noisy high gas-flow mixer. Oxymix will be available for about one-fourth the cost of a blender. The device is the result of a joint effort between the Australian medical device company NASCOR (Sydney) and CSIRO BioMedical Devices (Sydney). CSIRO is the Commonwealth Scientific and Industrial Research Organization of Australia.

"NASCOR went to CSIRO to help us develop this device because we knew of their expertise in gas flow and turbine technology,” said Dr. Howard Chilton, chairman of R&D at NASCOR. "CSIRO's mechanical design met all of our objectives in a most elegant fashion.”




Related Links:
NASCOR
CSIRO

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Isolation Stretcher
IS 736
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.